Vektor Medical Announces EP Europace Publication: vMap-Guided Ablation Associated with Improved One-Year Arrhythmia-Free Survival in Unstable Ventricular Tachycardia Patients

Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced the publication of a peer-reviewed study in EP Europace evaluating vMap-guided activation mapping and ...
Morningstar

First in Human Ischemic VT Ablation Successfully Performed in iCMR

The Amsterdam UMC team, shown here, performed the VT ablation procedure following previous experiences performing atrial flutter and premature ventricular complex (PVC) ablation procedures guided by ...
Medscape

High rate of VT recurrence in ARVD/C patients undergoing catheter ablation

Baltimore, MD - A report published this week has shown a high rate of ventricular tachycardia (VT) recurrence—as high as 75% at 14 months—in arrhythmogenic right ventricular dysplasia/cardiomyopathy ...
TCTMD

Preventive VT Ablation Before ICD Helps High-risk Ischemic Cardiomyopathy Patients

BERLIN, Germany—Performing ventricular tachycardia (VT) ablation before placement of a primary prevention implantable cardioverter-defibrillator (ICD) had a clinical benefit in a selected group of ...
Medscape

Radiation Ablation of VT: Dramatic Results in Small Series

ST LOUIS, MO — Stereotactic delivery of external-beam radiation can potentially be used to ablate the source of ventricular tachycardia (VT) that has resisted other drug and device treatments, ...
Healio

Mechanical circulatory support device does not impact outcomes in high-risk VT ablation

Please provide your email address to receive an email when new articles are posted on . High-risk patients getting catheter ablation for ventricular tachycardia did not benefit from a mechanical ...
MedPage Today

Impella Not Linked to Better VT Ablation Outcomes

NEW ORLEANS – The Impella 5.0 and 5.5 left ventricular assist device failed to measure up on outcomes when used for high-risk patients undergoing ventricular tachycardia (VT) ablation therapies, ...
Business Wire

Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM; “Adagio Medical”, “Adagio” or the “Company”), a leading innovator in catheter ablation technologies, today announced ...
TCTMD

VT, No Matter Its Source, Benefits From Early Catheter Ablation: PAUSE-SCD

Patients with structural heart disease and monomorphic ventricular tachycardia (VT), irrespective of its etiology, can benefit when early first-line catheter ablation is added before implanting an ...
EurekAlert!

Preventive ablation of ventricular tachycardia avoids shocks and hospitalisation

Berlin, Germany – 8 April 2024: The first randomised trial to investigate preventive ablation of a potential arrhythmogenic substrate associated with coronary chronic total occlusion (CTO) in patients ...
National Institute for Health and Care Excellence

Percutaneous (non-thoracoscopic) epicardial catheter radiofrequency ablation for ventricular tachycardia

Ventricular tachycardia (VT) is caused by abnormal electrical circuits originating from diseased areas of the ventricular myocardium. It usually results in a rapid heartbeat, preventing effective ...
Healio

STROKE-VT: DOACs superior to aspirin at stroke prevention after LV arrhythmia ablation

Please provide your email address to receive an email when new articles are posted on . Among patients who underwent LV arrhythmia ablation with a radiofrequency catheter, direct oral anticoagulants ...